Sindato, C, Karimuribo, ED, Vairo, F, Misinzo, G, Rweyemamu, MM, Hamid, MMA, Haider, N, Tungu, PK, Kock, R, Rumisha, SF, Mbilu, T, Ntoumi, F, Zumla, A and Mboera, LEG (2022) Rift Valley fever seropositivity in humans and domestic ruminants and associated risk factors in Sengerema, Ilala, and Rufiji districts, Tanzania. International Journal of Infectious Diseases, 122. 559 - 565. ISSN 1201-9712

[thumbnail of 2. 41. 2022. 3 Sindato et al Rift valley seropositivity in animals and humans_IJID_2022.pdf]
2. 41. 2022. 3 Sindato et al Rift valley seropositivity in animals and humans_IJID_2022.pdf - Published Version

Download (926kB) | Preview


Data on Rift Valley fever virus (RVFV) prevalence in urban settings and pastoral areas of Tanzania are scarce. We performed a cross-sectional study of RVFV seroprevalence and determinants in humans and animals from Ilala, Rufiji, and Sengerema districts of Tanzania.

Blood samples from the study participants were tested for anti-RVFV immunoglobulin G (IgG) antibodies using an enzyme-linked immunosorbent assay. Logistic regression was used to determine association between exposure risk practices and RVFV seropositivity.

The study involved 664 humans, 361 cattle, 394 goats, and 242 sheep. The overall anti-RVFV IgG seroprevalence in humans and animals was 2.1% (95% confidence interval [CI] 0.01-0.04) and 9.5% (n = 95, 95% CI 0.08-0.12), respectively. Seroprevalence in humans in Rufiji, Ilala, and Sengerema was 3.0% (n = 225, 95% CI 0.01-0.06), 1.8% (n = 230, 95% CI-0.005- 0.04), and 1.4% (n = 209, 95% CI 0.01-0.04), respectively (P >0.05). Seroprevalence in animals in Sengerema, Rufiji, and Ilala was 12.1% (n = 40, 95% CI 0.09-0.16), 11.1% (n = 37, 95% CI 0.08-0.15), and 5.4% (n = 18, 95% CI 0.03-0.08), respectively (P = 0.006). Handling of carcasses increased the odds of RVFV seropositivity 12-fold (odds ratio 11.84, 95% CI 1.97-71.16).

The study confirms previous occurrence of RVFV in multiple species in the study districts. Animal handling practices appear to be essential determinants of seropositivity.

Item Type: Article
Additional Information: © 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (
Subjects: R Medicine > R Medicine (General) > R735 Medical education. Medical schools. Research
Depositing User: Symplectic
Date Deposited: 02 Nov 2022 16:15
Last Modified: 02 Nov 2022 16:15

Actions (login required)

View Item
View Item